Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 16 studies | 23% ± 7% | |
| non-classical monocyte | 14 studies | 31% ± 15% | |
| B cell | 11 studies | 21% ± 4% | |
| classical monocyte | 11 studies | 27% ± 9% | |
| endothelial cell | 10 studies | 26% ± 10% | |
| epithelial cell | 8 studies | 38% ± 18% | |
| memory B cell | 8 studies | 19% ± 4% | |
| ciliated cell | 6 studies | 28% ± 7% | |
| monocyte | 6 studies | 23% ± 9% | |
| enterocyte | 6 studies | 30% ± 7% | |
| goblet cell | 6 studies | 24% ± 8% | |
| conventional dendritic cell | 5 studies | 30% ± 15% | |
| dendritic cell | 5 studies | 31% ± 16% | |
| plasmacytoid dendritic cell | 5 studies | 24% ± 7% | |
| endothelial cell of artery | 4 studies | 18% ± 1% | |
| myeloid cell | 4 studies | 28% ± 9% | |
| endothelial cell of lymphatic vessel | 4 studies | 28% ± 9% | |
| fibroblast | 4 studies | 26% ± 4% | |
| abnormal cell | 4 studies | 22% ± 6% | |
| secretory cell | 3 studies | 24% ± 5% | |
| pancreatic A cell | 3 studies | 20% ± 3% | |
| vein endothelial cell | 3 studies | 29% ± 15% | |
| retinal ganglion cell | 3 studies | 47% ± 23% | |
| endothelial cell of vascular tree | 3 studies | 18% ± 3% | |
| natural killer cell | 3 studies | 17% ± 1% | |
| enteroendocrine cell | 3 studies | 25% ± 8% | |
| neuron | 3 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 9626.14 | 258 / 258 | 100% | 31.36 | 230 / 230 |
| esophagus | 100% | 7708.37 | 1445 / 1445 | 100% | 44.14 | 183 / 183 |
| liver | 100% | 9573.19 | 226 / 226 | 100% | 31.31 | 406 / 406 |
| brain | 100% | 10614.97 | 2640 / 2642 | 100% | 31.16 | 705 / 705 |
| thymus | 100% | 7584.53 | 653 / 653 | 100% | 24.40 | 604 / 605 |
| uterus | 100% | 6875.77 | 170 / 170 | 100% | 34.38 | 458 / 459 |
| ovary | 100% | 9890.26 | 180 / 180 | 100% | 36.87 | 428 / 430 |
| pancreas | 100% | 8233.21 | 328 / 328 | 99% | 32.88 | 177 / 178 |
| prostate | 100% | 9399.59 | 245 / 245 | 99% | 39.59 | 499 / 502 |
| skin | 100% | 9143.21 | 1809 / 1809 | 99% | 37.75 | 469 / 472 |
| intestine | 100% | 9133.56 | 966 / 966 | 99% | 42.05 | 523 / 527 |
| stomach | 100% | 16116.00 | 359 / 359 | 99% | 46.20 | 283 / 286 |
| kidney | 100% | 10403.26 | 89 / 89 | 99% | 29.11 | 891 / 901 |
| breast | 100% | 7554.72 | 459 / 459 | 98% | 24.15 | 1101 / 1118 |
| bladder | 100% | 6766.19 | 21 / 21 | 98% | 33.11 | 496 / 504 |
| lung | 100% | 7190.94 | 577 / 578 | 98% | 28.75 | 1134 / 1155 |
| adipose | 100% | 7632.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 41.82 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 33.28 | 29 / 29 |
| muscle | 100% | 11238.36 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 10154.91 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 32.43 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 25.35 | 1 / 1 |
| blood vessel | 100% | 5927.26 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 10956.30 | 852 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 5828.96 | 915 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048568 | Biological process | embryonic organ development |
| GO_0006897 | Biological process | endocytosis |
| GO_0007219 | Biological process | Notch signaling pathway |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_1903671 | Biological process | negative regulation of sprouting angiogenesis |
| GO_0007565 | Biological process | female pregnancy |
| GO_0030125 | Cellular component | clathrin vesicle coat |
| GO_0005905 | Cellular component | clathrin-coated pit |
| GO_0005768 | Cellular component | endosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0030276 | Molecular function | clathrin binding |
| GO_0140313 | Molecular function | molecular sequestering activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005543 | Molecular function | phospholipid binding |
| Gene name | EPN1 |
| Protein name | Epsin 1 Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1) |
| Synonyms | |
| Description | FUNCTION: Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). Modifies membrane curvature and facilitates the formation of clathrin-coated invaginations (By similarity). Regulates receptor-mediated endocytosis . . |
| Accessions | ENST00000589704.1 ENST00000411543.6 [Q9Y6I3-1] Q9Y6I3 K7EMP4 ENST00000270460.11 [Q9Y6I3-2] ENST00000085079.11 [Q9Y6I3-3] |